Humana fascioloza u Srbiji lečena triklabendazolom
Sažetak
Uvod. Broj ljudi zaraženih parazitom Fasciola hepatica je u porastu širom sveta. Čovek postaje slučajan domaćin unošenjem infektivnih oblika, metacerkarija, kontaminiranom vodom ili biljkama. Prikaz bolesnika. U radu je prikazana 68-godišnja bolesnica iz Srbije, kod koje je nakon dijagnostičkog lutanja postavljena dijagnoza akutne fascioloze. Na osnovu kliničke slike (bol pod desnim rebarnim lukom, febrilnost, generalizovani bol), visoke eozinofilije i povišene aktivnosti alkalne fosfataze u serumu posumnjalo se na akutnu fasciolozu. U fecesu i duodenalnom aspiratu nisu nađena jaja Fasciola hepatica. U nedostatku imunološke dijagnostike za fasciolozu u Srbiji, dijagnoza je postavljena na osnovu prisustva specifičnih antitela imunoenzimskim testom i potvrđena imunoblot metodom u Institutu za tropske bolesti u Hamburgu, Nemačka. Lečenje je sprovedeno primenom triklabendazola, posle čega su se simptomi povukli, a biohemijske vrednosti vratile u normalu. Zaključak. Humana fascioloza može biti teška za dijagnostiku naročito u neendemskim područjima, gde kliničari retko pomisle na nju i gde je duga lista bolesti koje treba isključiti u diferencijalnoj dijagnostici. Sindrom eozinofilije, febrilnost i bolovi ispod desnog rebarnog luka sugerišu akutnu fasciolozu. Nejasan izvor infekcije ne isključuje fasciolozu.
Reference
Mas-Coma S, Bargues MD, Valero MA. Fascioliosis and other plantborne trematode zoonoses. Int J Parasitol 2005; 35(11–12): 1255–78.
Soliman MFM. Epidemiological review of human and animal fascioliosis in Egypt. J Infect Developing Countries 2008; 2(3): 182–9.
Arjona R, Riancho JA, Aguado JM, Salesa R, González-Macías J. Fasciolosis in developed countries: a review of classic and ab-errant forms of the disease. Medicine 1995; 74(1): 13–23.
Rajkovic-Janje R, Bosnic S, Kosier N, Husnjak M. Invasion with endoparasites in sheep, goats and bovine cattle and its signifi-cance. Praxis Veterinaria 2000; 48(1–2): 41–5 (Croatian)
Milanovic V, Nitovski A, Kulisic Z, Mirilovic M. Fasciola hepatica findings in cattle of Jablanica region (Serbia) Veterinarski glas-nik 2007; 61(1–2): 89–97. (Serbian)
Taira N, Yoshifuji H, Boray JC. Zoonotic potential of infection with Fasciola spp. by consumption of freshly prepared raw liver containing immature flukes. Int J Parasitol 1997; 27(7): 775–9.
Esteban JG, Bargues MD. Epidemiology of human fascioliosis: a review and proposed new classification. Bull WHO 1999; (77): 340–6.
Ehrhardt S, Burchard GD. Eosinophilia in returning travelers and migrants. Dtsch Arztebl Int 2008; 105(46): 801–7.
Saba R, Korkmaz M, Inan D, Mamikoglu L, Turhan O, Gunseren F et al. Human fascioliosis. Clin Microbiol Infect 2004; (10): 385–7.
Dauchy FA, Vincendeau P, Lifermann F. Eight cases of fasciolio-sis: clinical and microbiological features. Med Mal Infect 2006; 36(1): 42–6.
Haseeb AN, El-Shazly AM, Arafa MA, Morsy AT. Clinical, labo-ratory and ultrasonography features of proven human fascio-liosis. J Egypt Soc Parasitol 2003; 33(2): 397–412.
Pagola Serrano MA, Vega A, Ortega E, Gonzales A. Computed tomography of hepatic fascioliosis. J Comput Assist Tomog 1987; 11(2):269–72.
Han JK, Choi BI, Jae Min Cho, Chung KB, Han MC, Kim CW. Ra-diological findings of human fascioliosis. Abdom Imaging 1993; 18(3): 261–4.
Marcos LA, Tagle M, Terashima A, Bussalleu A, Ramirez C, Carrasco C, et al. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fasciolosis. Am J Trop Med Hyg 2008; 78(2): 222–7.
Taheri MS, Aminzade Z, Shokohi Sh, Birang Sh, Aghazade K. Case Report. Hepatobiliary fascioliosis: clinical and radiological fea-tures. Iranian J Parasitol 2007; 2(4): 48–55.
Kabaalioglu A, Ceken K, Alimoglu E, Saba R, Cubuk M, Arslan G, et al. Hepatobiliary fascioliosis: sonographic and CT findings in 87 patients during the initial phase and long-term follow-up. AJR Am J Roentgenol 2007; 189(4): 824–8.
Moghadami M, Mardani M. Fasciola hepatica: A cause of ob-structive jaundice in an elderly man from Iran. Saudi J Gastro-enterology 2008; 14(4): 208–10.
Espino AM, Díaz A, Pérez A, Finlay CM. Dynamics of anti-genemia and coproantigens during a human Fasciola hepatica outbreak. J Clin Microbiol 1998; 36(9): 2723–6.
Acosta-Ferreira W, Vercelli-Retta J, Falconi LM. Fasciola hepatica human infection. Histopathological study of sixteen cases. Vir-chows Arch A Path Anat Histol 1979; 383(3): 319–27.
Hernandez RJ, Blasco CA, Valdivieso BMF, Arribas MMI, Pa-ciencia AM, Rodríguez SE, et al. Familial outbreaks of fascioliosis: usefulness of serologic investigation by enzyme immunoassay. Rev Clin Esp 1998; (198): 33–5.
Mansour WA, Kaddah MA, Sjaker ZA, al Assal FM, Derbala MF. A monoclonal antibody diagnoses active fasciola infection in humans. J Egypt Soc Parasitol 1998; 28(3): 711−27.
World Health Organization. WHO/CDS/NTD/PCT/2007.1. Report of the WHO Informal Meeting on use of triclabenda-zole in fasciolosis control. WHO headquarters, Geneva, Swit-zerland: World Health Organization; 2006.
Rossignol JF, Abaza H, Friedman H. Successful treatment of human fascioliosis with nitazoxanide. Trans R Soc Trop Med Hyg 1998; 92(1): 103–4.
Hien TT, Truong NT, Minh NH, Dat HD, Dung NT, Hue NT, et al. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliosis in central Vietnam. Am J Trop Med Hyg 2008; 78(3): 388–92.
Keiser J, Engels D, Buscher G, Utzinger J. Triclabendazole for the treatment of fascioliosis and paragonimiosis. Expert Opin In-vestig Drugs 2005; 14(12): 1513–26.
